Ellen Friche
- Molecular Biology
- Oncology top 5%
- Toxicology top 5%
- Organic Chemistry
- Cardiology and Cardiovascular Medicine
- Co-authors
- Erland J.F. DemantMaxwell SehestedPeter Buhl JensenTorben SkovsgaardMary K. DanksWilliam T. BeckBoe Sandahl SørensenNis I. Nissen
- Topics
- Cancer therapeutics and mechanisms (20 papers)Drug Transport and Resistance Mechanisms (17 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)
- Cited by
- ToxicologyOncologyMolecular Biology
- Partner nations
- DenmarkUnited States
In The Last Decade
Ellen Friche
28 papers receiving 704 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 500
- Oncology 496
- Toxicology 71
- Organic Chemistry 61
- Cardiology and Cardiovascular Medicine 56
Countries citing papers authored by Ellen Friche
This map shows the geographic impact of Ellen Friche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Friche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Friche more than expected).
Fields of papers citing papers by Ellen Friche
This network shows the impact of papers produced by Ellen Friche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Friche. The network helps show where Ellen Friche may publish in the future.
Co-authorship network of co-authors of Ellen Friche
This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Friche. A scholar is included among the top collaborators of Ellen Friche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Friche. Ellen Friche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 9 | |
| 3 | 14 | |
| 4 | 18 | |
| 5 | 19 | |
| 6 | 6 | |
| 7 | 81 | |
| 8 | 54 | |
| 9 | 31P and 13C NMR spectroscopic study of wild type and multidrug resistant Ehrlich ascites tumor cells. | 4 |
| 10 | 21 | |
| 11 | 32 | |
| 12 | 10 | |
| 13 | Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. | 68 |
| 14 | 24 | |
| 15 | 13 | |
| 16 | 25 | |
| 17 | The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. | 72 |
| 18 | 11 | |
| 19 | 15 | |
| 20 | 4 |
About Ellen Friche
Ellen Friche is a scholar working on Oncology, Toxicology and Molecular Biology, having authored 28 papers that have together received 733 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (20 papers), Drug Transport and Resistance Mechanisms (17 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Toxicology (71 citations), Oncology (496 citations) and Molecular Biology (500 citations). Ellen Friche has collaborated with scholars based in Denmark and United States. Frequent co-authors include Erland J.F. Demant, Maxwell Sehested, Peter Buhl Jensen, Torben Skovsgaard, Mary K. Danks, William T. Beck, Boe Sandahl Sørensen, Nis I. Nissen, Carla Schmidt and Heine H. Hansen. Their work appears in journals such as Analytical Biochemistry, British Journal of Cancer and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.